Andrea Mothe

Krembil Research Institute

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (7)

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

philippe monnier

University Health Network

CANADA

View details

Michael Gold

Chief R&D Officer

UNITED KINGDOM

View details

Alireza P. Shabanzadeh

Korea Brain Research Institute

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Andrea Mothe

Research Interests

Explore related searches

Contact this professor

Articles (7)

Neutralizing RGMa with Elezanumab Promotes Cerebroprotection and Recovery in Rabbit Middle Cerebral Artery Occlusion

Excitotoxic glutamate levels drive spinal cord ependymal stem cell proliferation and fate specification through CP-AMPAR signaling

Delayed administration of elezanumab, a human anti-RGMa neutralizing monoclonal antibody, promotes recovery following cervical spinal cord injury

Cholesterol synthesis inhibition promotes axonal regeneration in the injured central nervous system

Elezanumab, a human anti-RGMa monoclonal antibody, promotes neuroprotection, neuroplasticity, and neurorecovery following a thoracic hemicompression spinal cord injury in non-human primates.

Delayed administration of the human anti-RGMa monoclonal antibody elezanumab promotes functional recovery including spontaneous voiding after spinal cord injury in rats

The leading edge: Emerging neuroprotective and neuroregenerative cell-based therapies for spinal cord injury.

Collaborators (3)

philippe monnier

Michael Gold

Alireza P. Shabanzadeh

Make your next move.